GlassScriptPhysician profile
Susan M Odonnell
NPI 1720051162
$859.80
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.27 · 2020: $94.19 · 2021: $196 · 2022: $165 · 2023: $231 · 2024: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $151.28 | 2021-2024 | |
| Abbott Laboratories | $125.57 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $115.68 | 2020-2024 | Mounjaro |
| Amgen INC. | $89.24 | 2021-2023 | Otezla, Repatha |
| Novo Nordisk INC | $85.13 | 2019-2023 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $44.11 | 2021-2022 | |
| Glaxosmithkline, LLC. | $42.22 | 2019-2022 | |
| Philips North America LLC | $32.95 | 2022 | |
| Janssen Pharmaceuticals, INC | $29.76 | 2020 | |
| Sumitomo Pharma America, INC. | $26.40 | 2023 | Gemtesa |
| Amarin Pharma, INC. | $21.08 | 2021 | |
| Sunovion Pharmaceuticals INC. | $16.77 | 2019 | |
| Phathom Pharmaceuticals, INC. | $15.50 | 2024 | Voquezna |
| Paratek Pharmaceuticals, INC. | $13.66 | 2021 | |
| Pfizer INC. | $13.12 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $12.86 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.76 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Odonnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.